Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP-WT-2001 Registry.
Authors
Dávila Fajardo, ROldenburger, E
Rübe, C
López-Yurda, M
Pritchard-Jones, K
Bergeron, C
Graf, N
van Grotel, M
van Tinteren, H
Saunders, Daniel
van den Heuvel-Eibrink, M
Janssens, G
Oldenburger, F
Affiliation
Department of Radiation Oncology, University Medical Center Utrecht and Princess Maxima Center for Pediatric Oncology, Utrecht, The NetherlandsIssue Date
2018-04-25
Metadata
Show full item recordAbstract
To evaluate the value of radiotherapy boost omission in patients with intermediate-risk, stage III Wilms tumours (WT) with positive lymph nodes (LN).Citation
Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP-WT-2001 Registry. 2018, Pediatr Blood CancerJournal
Pediatric Blood & CancerDOI
10.1002/pbc.27085PubMed ID
29693799Type
ArticleLanguage
enISSN
1545-5017ae974a485f413a2113503eed53cd6c53
10.1002/pbc.27085
Scopus Count
Collections
Related articles
- Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
- Authors: Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N, SIOP Renal Tumours Study Group
- Issue date: 2015 Sep 19
- Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.
- Authors: Fajardo RD, van den Heuvel-Eibrink MM, van Tinteren H, Spreafico F, Acha T, Bergeron C, de Camargo B, Oldenburger F, Rübe C, Oue T, Vokuhl C, de Krijger RR, Vujanic G, Sebire N, Coulomb-L'Hermine A, Collini P, Gandola L, Pritchard-Jones K, Graf N, Janssens GO, van Grotel M
- Issue date: 2020 Feb
- Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
- Authors: Spreafico F, Gandola L, D'Angelo P, Terenziani M, Collini P, Bianchi M, Provenzi M, Indolfi P, Pession A, Nantron M, Di Cataldo A, Marchianò A, Catania S, Fossati Bellani F, Piva L, AIEOP Wilms Tumor Working Group
- Issue date: 2012 Jan 1
- Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.
- Authors: Grundy RG, Hutton C, Middleton H, Imeson J, Pritchard J, Kelsey A, Marsden HB, Vujanic GM, Taylor RE, United Kingdom Children's Cancer Study Group
- Issue date: 2004 Apr
- Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience.
- Authors: Wilde JC, Aronson DC, Sznajder B, Van Tinteren H, Powis M, Okoye B, Cecchetto G, Audry G, Fuchs J, Schweinitz DV, Heij H, Graf N, Bergeron C, Pritchard-Jones K, Van Den Heuvel-Eibrink M, Carli M, Oldenburger F, Sandstedt B, De Kraker J, Godzinski J
- Issue date: 2014 Dec